Q: Is Radiance primarily an acne treatment or a pigmentation treatment?
A: It is designed with both concerns in mind. Clindamycin, tretinoin, and azelaic acid provide acne-focused activity, while tranexamic acid and azelaic acid are relevant to uneven pigmentation and post-inflammatory discoloration.
Q: What are the dark marks that remain after a breakout?
A: Acne and other inflammation can leave areas of increased pigmentation after the blemish itself has resolved. This is commonly called post-inflammatory hyperpigmentation, or PIH, and is different from an active acne lesion.
Q: Does Radiance treat acne scars?
A: Radiance is better suited to concerns involving active acne and post-inflammatory discoloration. Indented or raised acne scars involve structural changes in the skin and may require different treatment approaches.
Q: Why is tranexamic acid included?
A: Topical tranexamic acid has been studied for its effects on pathways involved in excess pigmentation. In Radiance, it provides a targeted component for concerns involving uneven tone and post-inflammatory dark marks.
Q: Why does the formula include dexpanthenol and niacinamide?
A: Active acne treatments can sometimes be drying or irritating. Dexpanthenol and niacinamide provide complementary moisturizing and barrier-supporting properties within the formula.
Q: How long is Radiance typically used?
A: An initial course of approximately 8–12 weeks may be used to assess acne response, pigmentation changes, and skin tolerance. Because Radiance contains clindamycin, our healthcare provider should determine whether treatment continues or changes after reassessment.